Erectile dysfunction (ED) is a common complication of diabetes, while the erythrocyte aldose reductase (AR) is involved in a variety of diabetic complications.
Kyoto Prefecture Medical University, Department of Urology of the Naya Y, and colleagues studied 62 patients with diabetes, of which 25 cases had blood dialysis treatment (CRF chronic renal failure group), the remaining 37 cases of non-chronic renal failure group (DM group). The researchers selected 20 patients with age-matched healthy volunteers as controls, and all patients and controls were measured by quantitative AR Kit AR level. Diagnosis of ED includes five elements according to the International Index of Erectile Function (IIEF-5) derived.
The researchers found that, CRF group, the average level of AR was significantly higher than DM group and control group (P <0.001).>
Naya and so concluded that these results show that the AR level may be as a predictor of ED patients with diabetes an effective means of disease.
